Last reviewed · How we verify

Fospropofol disodium for injection

Xiaobo Yang, MD · Phase 2 active Small molecule

Fospropofol disodium is a prodrug that is converted to propofol, a GABA_A receptor agonist, leading to sedation and hypnosis.

Fospropofol disodium is a prodrug that is converted to propofol, a GABA_A receptor agonist, leading to sedation and hypnosis. Used for Sedation for diagnostic or surgical procedures.

At a glance

Generic nameFospropofol disodium for injection
Also known asRemifentanil, sulfentanyl
SponsorXiaobo Yang, MD
Drug classGABA_A receptor agonist
TargetGABA_A receptor
ModalitySmall molecule
Therapeutic areaAnesthesiology
PhasePhase 2

Mechanism of action

Fospropofol disodium is a water-soluble prodrug that is metabolized to propofol, which then acts as a potent agonist of the GABA_A receptor. This results in the enhancement of inhibitory neurotransmission in the brain, leading to sedative and hypnotic effects.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results